Christopher B. Carson

Director
412.297.4824
 

As Head of the Business/Tax Group, Mr. Carson focuses in the areas of general corporate and securities law, with particular emphasis on mergers and acquisitions, including auction-based transactions, negotiated acquisitions, takeover counseling, international joint ventures and corporate finance.  He has particular expertise in the biotechnology, pharmaceuticals and chemicals industries.  He is listed in The Best Lawyers in America for business law and in Philadelphia Magazine’s “ Pennsylvania Super Lawyers.”

Education

  • J.D. (Honors – Legal Research and Writing), University of Pittsburgh School of Law, 1985
  • B.A. (cum laude, Omicron Delta Kappa National Leadership Society), Dickinson College, 1982

Noteworthy

  • Listed in The Best Lawyers in America for business law
  • Listed in Philadelphia Magazine’s “Pennsylvania Super Lawyers.”

Representative Matters

  • Merger of diabetes care/blood glucose monitoring business Metrika Inc. (Sunnyvale, CA) with subsidiary of Bayer Healthcare Inc., July 2006
  • Acquisition of share capital of chemical/gas detection business Oldham, S.A. (Arras, France) and Winter GmbH by Industrial Scientific Corporation, May 2006
  • Co-Promotion Agreement for Nexavar® oncology drug between Onyx Pharmaceuticals, Inc. (Emeryville, CA) and Bayer Pharmaceuticals Corporation, March 2006
  • Auction-based sale of commercial/residential gas connector manufacturing business to Watts Water Technologies, Inc. (North Andover, MA) for $95mm, December 2005
  • Collaboration Agreement for the development of a novel pharmaceutical compound between Nektar Pharmaceuticals (San Carlos, CA) and Bayer HealtCare AG, December 2004
  • Collaboration and License Agreement related to proprietary antibody technology between Seattle Genetics, Inc. (Bothell, WA) and Bayer Pharmaceuticals Corporation, September 2004
  • The first promotional rights/trademark license agreement of its kind with the National Football League for the marketing of a men’s health pharmaceutical compound, April 2003
  • Sale of industrial air dryer division of multinational corporation, Hansen Inc., to Flair Corporation, February 2003
  • Joint venture to develop, manufacture and sell certain proprietary compact disc related technology utilizing polycarbonate film, October 2002
  • Sale of Instrumentation Engineering, Inc. to Flextronics Ltd. of Singapore in stock-for-stock exchange, August 2001
  • Acquisition of CGMP sunscreen additive product line and technology of C.P. Hall Company by German concern, July 2001
  • Sale of biochemical business unit of Sybron Chemicals Inc. to Novazymes A/S of Denmark, May 2001
  • Auction-based acquisition of flooring adhesives division of Armstrong World Industries by Ardex, Inc., July 2000
  • Disposition of capital stock of Abel Industries, Inc., a U.S. and German manufacturer of proprietary piston and membrane pumps, to Roper Industries, Inc., June 2000
  • Acquisition of proprietary designer of rolling mill coating surfaces and chemicals by German engineering firm, March 2000
  • Acquisition of custom manufacturer of chemical dispersion products by German chemical firm, November 1999
  • Acquisition of research-based biotech/diagnostic tool manufacturing firm based in Cambridge, Massachusetts by German medical diagnostic firm, November 1999
  • Joint venture for the manufacture and sale of competitive swimwear on behalf of German concern, August 1999
  • Acquisition of polycarbonate sheet extrusion business of Dutch chemical concern, 1999
  • Disposition of U.S. latex paper coatings business of German joint venture, 1998
  • International research and development joint venture for proprietary developments in the automotive glass industry, 1998
  • Represented an international chemical concern in connection with series of project finance, joint venture and corporate partnering arrangements at its integrated chemical production facility, 1997-1999
  • Acquisition of equity interest in generic pharmaceutical manufacturer, 1996
  • Acquisition of international flavor and fragrance manufacturer with subsidiaries in 15 countries, 1995
  • Research and development joint venture with medical research firm, 1994
  • Acquisition of manufacturing concern based in Helsinki with operations in Germany, Belgium, Japan and U.S., 1994
  • Disposition of Seattle-based Federal Savings Bank for $690 million, 1993
  • Regular representations of Fortune 100 and multinational companies, and venture capitalists

Memberships

  • Chair, Individual Gifts Committee, Carnegie Museums of Pittsburgh
  • Member, Pennsylvania Bar Association
  • Member, Allegheny County Bar Association

Publications

  • Author, The Unintended Consequences of Confidentiality Agreements in the Auction Context, Cohen & Grigsby Review (Fall/Winter 1999)
  • Author, Delaware Takes a Quickturn Away From Pennsylvania, Cohen & Grigsby Review (Spring 1999)
  • Author, Ambassadors of the Profession, Pennsylvania Bar Association Journal (Spring 1997)
  • Author, New Legislation in Pennsylvania Strengthens Takeover Defenses, Comment to Clients (June 21, 1990)